👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

UK on course for COVID-19 vaccination target as shots reach 200,000 a day: Hancock

Published 2021-01-10, 08:58 a/m
© Reuters. The outbreak of the coronavirus disease (COVID-19), in Hemel Hempstead

By Paul Sandle

LONDON (Reuters) - Britain is on course to have immunised its most vulnerable people against COVID-19 by mid-February and offering a shot to every adult by autumn, with some 2 million people having already received a first dose, its health secretary said on Sunday.

"Over the last week we've vaccinated more people than in the entirety of December, so we're accelerating the roll-out," Matt Hancock told BBC TV.

Britain is battling surging infections but is pinning its hopes on rapid immunisation to enable life to start returning to some degree of normality by the spring.

Hancock said around 2 million people had already received a first shot of the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine.

"We've now vaccinated around a third of all of the over 80s, so (we are making) very, very good progress," he said.

For the government to meet its goal of vaccinating more than 14 million people by mid-February, comprising the over-70s, the clinically vulnerable - the elderly or with pre-existing conditions - and health and social-care workers, it needs to deliver 2 million shots a week.

The current rate is around 200,000 a day, Hancock said.

Seven mass vaccination centres will open this week, supplementing almost 1,000 doctors surgeries and hospitals offering shots. Hancock said every adult would be offered a vaccine by the autumn.

Queen Elizabeth and her husband Philip, both in their nineties, have received vaccinations, Buckingham Palace said on Saturday.

SURGING CASES

A highly transmissible new variant of the virus is surging around Britain and Prime Minister Boris Johnson has imposed a third national lockdown in England to try to stem the pandemic before the most vulnerable are immunised. Wales, Scotland and Northern Ireland have imposed similar measures.

More than 80,000 people in Britain have died within 28 days of receiving a positive COVID-19 test, the fifth highest official death toll globally, and over 3 million people have tested positive.

England's Chief Medical Officer Chris Whitty said on Sunday the national health service in parts of the country was facing "the most difficult situation anyone could remember".

© Reuters. The outbreak of the coronavirus disease (COVID-19), in Hemel Hempstead

Hancock did not rule out a tougher lockdown, saying he would "not speculate" on further restrictions, although he added that the "vast majority" of people were complying with current rules.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.